Search results
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 4 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 1 day agoOn Friday, Moderna Inc. (NASDAQ:MRNA) announced that it has submitted an FDA application for review...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
CNN.com· 22 hours agoThe US Food and Drug Administration announced Friday that it had advised the makers of the Covid-19...
Paxlovid Fails to Quell Long Covid Symptoms in Stanford Study
Bloomberg· 1 day agoA 15-day course of Pfizer Inc.’s antiviral Paxlovid didn’t provide significant relief for long Covid...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga· 4 days agoOn Friday, Pfizer Inc PFE revealed its drug for an advanced form of lung cancer showed promising...
Relay Therapeutics to Collaborate with Pfizer to Evaluate Breast Cancer Treatment
Market Watch· 3 days agoRelay Therapeutics will collaborate with Pfizer to study atirmociclib in combination with RLY-2608 and fulvestrant in patients with certain types of metastatic breast cancer ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoBiotech stock hit a two-year high in February, but have trended sideways in the months since despite...
Potential Price Increase for Pfizer Inc.
Knox Daily· 6 days agoPfizer Inc.’s filing revealed that its Director Gottlieb Scott acquired Company’s shares for reported $79401.0 on Dec 15 ’23. In the deal valued at $26.47 per share,3,000 ...
FDA approves first RSV vaccine for use in at-risk adults over 50
The Hill via Yahoo News· 7 hours agoThe Food and Drug Administration (FDA) recently approved an expansion of a respiratory syncytial...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 3 days agoTwo other RSV vaccines, Arexvy from GlaxoSmithKline (GSK) and Abrysvo from Pfizer, received FDA...
